![Douglas Sheehy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Sheehy
Conseiller Juridique Général chez
MIRUM PHARMACEUTICALS, INC.
Profil
Mr. Douglas T.
Sheehy is a Chief Legal Officer & Secretary at Mirum Pharmaceuticals, Inc. He is on the Board of Directors at Aimmune Therapeutics UK Ltd. Mr. Sheehy was previously employed as a Secretary & General Counsel by Aimmune Therapeutics, Inc., a Secretary & Chief Legal Officer by Sonoma Biotherapeutics, Inc., a Secretary, Chief Administrative Officer & EVP by Codexis, Inc., an Executive Director-Legal & Corporate Law by CV Therapeutics, Inc., an Attorney by Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP, and an Attorney by Brobeck, Phleger & Harrison LLP.
He received his undergraduate degree from Dartmouth College and a graduate degree from American University Washington College of Law.
Postes actifs de Douglas Sheehy
| Sociétés | Poste | Début |
|---|---|---|
| MIRUM PHARMACEUTICALS, INC. | Conseiller Juridique Général | 19/05/2025 |
Aimmune Therapeutics UK Ltd.
 Aimmune Therapeutics UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | 31/03/2017 |
Anciens postes connus de Douglas Sheehy
| Sociétés | Poste | Fin |
|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | Conseiller Juridique Général | 01/12/2020 |
Sonoma Biotherapeutics, Inc.
 Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in research, development and manufacturing cell and genetic therapy for autoimmune and degenerative diseases | Conseiller Juridique Général | 01/01/2020 |
| CODEXIS, INC. | Directeur Administratif | 01/04/2016 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Conseiller Juridique Général | 01/04/2007 |
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP
 Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01/08/2000 |
Formation de Douglas Sheehy
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
84
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Health Technology |
Codexis, Inc.
 Codexis, Inc. Chemicals: SpecialtyProcess Industries Develops biocatalytic chemical processes | Process Industries |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Brobeck, Phleger & Harrison LLP
 Brobeck, Phleger & Harrison LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of desensitization treatments for peanut and food allergies | Health Technology |
American University Washington College of Law
 American University Washington College of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mirum Pharmaceuticals, Inc.
 Mirum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage therapeutics company developing a novel approach for treating cholestasis liver diseases | Health Technology |
Aimmune Therapeutics UK Ltd.
Aimmune Therapeutics UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Sonoma Biotherapeutics, Inc.
Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in research, development and manufacturing cell and genetic therapy for autoimmune and degenerative diseases | Health Technology |
